[go: up one dir, main page]

WO2008149140A3 - Tegaserod oxalate and polymorphic forms - Google Patents

Tegaserod oxalate and polymorphic forms Download PDF

Info

Publication number
WO2008149140A3
WO2008149140A3 PCT/GB2008/050396 GB2008050396W WO2008149140A3 WO 2008149140 A3 WO2008149140 A3 WO 2008149140A3 GB 2008050396 W GB2008050396 W GB 2008050396W WO 2008149140 A3 WO2008149140 A3 WO 2008149140A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymorphic forms
tegaserod
oxalate
relates
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/050396
Other languages
French (fr)
Other versions
WO2008149140A2 (en
Inventor
Abhay Gaitonde
Bindu Manojkumar
Sandeep Sonawane
Dattatrey Kokane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Mylan Pharmaceuticals Pvt Ltd
Original Assignee
Generics UK Ltd
Mylan Development Centre Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd, Mylan Development Centre Pvt Ltd filed Critical Generics UK Ltd
Publication of WO2008149140A2 publication Critical patent/WO2008149140A2/en
Publication of WO2008149140A3 publication Critical patent/WO2008149140A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel polymorphic forms of the oxalate salt of tegaserod,and to processes for the preparation of these novel polymorphic forms. The invention also relates to pharmaceutical compositions comprising these novel polymorphs,and to uses of said compositions for treating patients suffering from gastrointestinal disorders.
PCT/GB2008/050396 2007-06-04 2008-05-30 Tegaserod oxalate and polymorphic forms Ceased WO2008149140A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1039/MUM/2007 2007-06-04
IN1039MU2007 2007-06-04

Publications (2)

Publication Number Publication Date
WO2008149140A2 WO2008149140A2 (en) 2008-12-11
WO2008149140A3 true WO2008149140A3 (en) 2009-07-30

Family

ID=39737115

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/050396 Ceased WO2008149140A2 (en) 2007-06-04 2008-05-30 Tegaserod oxalate and polymorphic forms

Country Status (1)

Country Link
WO (1) WO2008149140A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0505322A1 (en) * 1991-03-22 1992-09-23 Sandoz Ltd. Aminoguanidines
WO2005058819A2 (en) * 2003-12-16 2005-06-30 Teva Pharmaceutical Industries Ltd. Polymorphic forms of tegaserod base and salts thereof
WO2006116953A1 (en) * 2005-05-02 2006-11-09 Zentiva, A.S. A method for the preparation of tegaserod and slected salts thereof
WO2008077871A1 (en) * 2006-12-22 2008-07-03 Novartis Ag Salts of tegaserod

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0505322A1 (en) * 1991-03-22 1992-09-23 Sandoz Ltd. Aminoguanidines
WO2005058819A2 (en) * 2003-12-16 2005-06-30 Teva Pharmaceutical Industries Ltd. Polymorphic forms of tegaserod base and salts thereof
WO2006116953A1 (en) * 2005-05-02 2006-11-09 Zentiva, A.S. A method for the preparation of tegaserod and slected salts thereof
WO2008077871A1 (en) * 2006-12-22 2008-07-03 Novartis Ag Salts of tegaserod

Also Published As

Publication number Publication date
WO2008149140A2 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
WO2009111700A3 (en) Oxadiazoanthracene compounds for the treatment of diabetes
WO2009064460A3 (en) Gastrointestinal delivery systems
WO2008132139A3 (en) New heterocyclic derivatives useful for the treatment of cns disorders
WO2009067686A3 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
WO2009104021A3 (en) Novel polymorphs and processes for their preparation
WO2008152099A3 (en) Aryl/hetarylamides as modulators of the ep2 receptor
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
TW200612892A (en) Novel compounds
IL204886B (en) Pharmaceutical composition for treating gastrointestinal disorders independent of the intake of food
WO2010055082A3 (en) New crystal form of sunitinib malate
TW200631583A (en) Substituted pteridines for the treatment of inflammatory diseases
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
WO2007052023A3 (en) Novel compounds
TW200745003A (en) Novel compounds
WO2010089327A3 (en) Indole derivatives as anticancer agents
WO2011023367A3 (en) Bisphosphonate-prodrugs
TW200621690A (en) Novel compounds
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2010049449A3 (en) Novel salts of sunitinib
WO2006058869A3 (en) Substituted pteridines for treating inflammatory diseases
WO2009109501A3 (en) Ocular pharmaceutical compositions
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2006056607A8 (en) Substituted pteridines for treating inflammatory diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08750791

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08750791

Country of ref document: EP

Kind code of ref document: A2